GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Genomtec SA (WAR:GMT) » Definitions » Total Liabilities

Genomtec (WAR:GMT) Total Liabilities : zł11.56 Mil (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Genomtec Total Liabilities?

Genomtec's Total Liabilities for the quarter that ended in Mar. 2024 was zł11.56 Mil.

Genomtec's quarterly Total Liabilities declined from Sep. 2023 (zł8.89 Mil) to Dec. 2023 (zł7.67 Mil) but then increased from Dec. 2023 (zł7.67 Mil) to Mar. 2024 (zł11.56 Mil).

Genomtec's annual Total Liabilities increased from Dec. 2021 (zł3.49 Mil) to Dec. 2022 (zł6.87 Mil) and increased from Dec. 2022 (zł6.87 Mil) to Dec. 2023 (zł7.67 Mil).


Genomtec Total Liabilities Historical Data

The historical data trend for Genomtec's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genomtec Total Liabilities Chart

Genomtec Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Liabilities
Get a 7-Day Free Trial 1.79 1.80 3.49 6.87 7.67

Genomtec Quarterly Data
Dec18 Dec19 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.94 8.47 8.89 7.67 11.56

Genomtec Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Genomtec's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=3.144+(1.11+3.416
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=7.67

Total Liabilities=Total Assets (A: Dec. 2023 )-Total Equity (A: Dec. 2023 )
=15.972-8.302
=7.67

Genomtec's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=7.371+(1.011+3.1
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0.082)
=11.56

Total Liabilities=Total Assets (Q: Mar. 2024 )-Total Equity (Q: Mar. 2024 )
=17.208-5.644
=11.56

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Genomtec Total Liabilities Related Terms

Thank you for viewing the detailed overview of Genomtec's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Genomtec (WAR:GMT) Business Description

Traded in Other Exchanges
Address
ul. Stab?owicka 147, PORT Building 2, Wroclaw, POL, 54-066
Genomtec SA is an innovative technology company which works in the area of ?? molecular diagnostics. It is a manufacturer of mobile molecular analyzers. The device are designed to identify pathogens including viruses, bacteria, and fungi by amplifying and detecting specific DNA and RNA fragments.

Genomtec (WAR:GMT) Headlines

No Headlines